Tigecycline option for the treatment of bone and joint infections caused by multidrug-resistant Staphylococcus epidermidis

Joint Bone Spine. 2012 Jan;79(1):97-9. doi: 10.1016/j.jbspin.2011.05.025. Epub 2011 Aug 3.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Bone Diseases, Infectious / drug therapy*
  • Bone Diseases, Infectious / microbiology
  • Drug Resistance, Multiple, Bacterial*
  • Female
  • Humans
  • Joint Diseases / drug therapy*
  • Joint Diseases / microbiology
  • Male
  • Middle Aged
  • Minocycline / analogs & derivatives*
  • Minocycline / therapeutic use
  • Staphylococcal Infections / complications
  • Staphylococcal Infections / drug therapy*
  • Staphylococcus epidermidis / drug effects*
  • Staphylococcus epidermidis / physiology
  • Tigecycline
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Tigecycline
  • Minocycline